We guide innovative medical technology companies through every critical step of development and commercialization
From early-stage startups to established device companies, we help medical technology innovators navigate the complex US healthcare landscape.
Success in MedTech requires alignment. We build integrated strategies that ensure your regulatory pathway supports your reimbursement strategy, your clinical evidence satisfies both FDA and payers, and your commercial approach leverages every advantage we create.
FDA submissions, 510(k), PMA, Breakthrough Device Designation
Market access, coding & coverage, payer strategy, New technology payments, field team operations
EFS & Pivotal trial design and staffing, KOL engagement, RWE
Early market development, systems and infrastructure design, contract sales team
FLEXIBLE ENGAGEMENTS
U.S. market entry requires specialized teams who understand FDA pathways, clinical execution, reimbursement mechanics, and provider adoption. UnifiMed provides specialized MedTech staffing across regulatory, clinical, reimbursement, and commercial domains, embedded directly into your execution plan.
Our teams are purpose-built for MedTech companies preparing for or entering the US market. We deploy highly-trained professionals who operate as an extension of your organization, aligned to your stage, evidence strategy, and commercialization objectives, without the burden of building full internal teams prematurely.
From fractional executives to full project teams, we scale precisely where execution risk is highest, ensuring continuity between planning and real-world delivery.
Regulatory experts supporting FDA strategy, submissions, compliance execution, and audit readiness
Reimbursement experts supporting coverage, coding, payment pathways, and proper provider billing
Clinical personnel supporting clinical trials, procedural execution, site operations, and evidence generation
Commercial teams accelerating market adoption, field team execution, and scalable early revenue generation
WHY UNIFIMED
UnifiMed was built by leaders who have operated inside MedTech companies at the points where execution risk is highest. Our experience spans regulatory strategy and FDA interaction, reimbursement and CMS policy, clinical operations and evidence development, and commercial execution across early-stage and market-leading MedTech companies
We have led U.S. market entry as first-in-market operators, built commercialization functions from the ground up, managed reimbursement strategy across inpatient and outpatient settings, and aligned clinical evidence to payer and provider decision-making. That experience shapes how we structure every engagement.
Rather than offering siloed expertise, we operate as an integrated execution partner, ensuring regulatory decisions support reimbursement outcomes, clinical strategy supports adoption, and commercial plans reflect real-world provider and payer behavior.
We support MedTech companies at critical inflection points, from regulatory strategy through early commercialization, where execution quality determines outcomes.
Add Your Heading Text Here
First to market in deep brain stimulation First to market in deep brain stimulation First to market in deep brain stimulation First to market in deep brain stimulation
Cardiovascular
First to market in deep brain stimulation
Cardiovascular
First to market in deep brain stimulation
Cardiovascular
First to market in deep brain stimulation
Cardiovascular
First to market in deep brain stimulation
Let’s discuss how UnifiMed can help you navigate the complexities of U.S. MedTech commercialization
